BANK VONTOBEL/CALL/SIEMENS HEALTHINEERS/64/0.1/20.06.25 Stock

Warrant

DE000VD4G232

Market Closed - Boerse Frankfurt Warrants 01:43:51 2024-07-05 pm EDT
0.186 EUR +1.64% Intraday chart for BANK VONTOBEL/CALL/SIEMENS HEALTHINEERS/64/0.1/20.06.25
Current month-6.53%
1 month-25.60%
Date Price Change
24-07-05 0.186 +1.64%
24-07-04 0.183 -0.54%
24-07-03 0.184 -4.66%
24-07-02 0.193 -3.50%
24-07-01 0.2 +0.50%

Real-time Boerse Frankfurt Warrants

Last update July 05, 2024 at 01:43 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SIEMENS HEALTHINEERS AG
IssuerLogo Issuer Vontobel Vontobel
WKN VD4G23
ISINDE000VD4G232
Date issued 2024-04-18
Strike 64
Maturity 2025-06-20 (348 Days)
Parity 10 : 1
Emission price 0.18
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.28
Lowest since issue 0.161
Spread 0.012
Spread %5.97%

Company Profile

Siemens Healthineers AG is one of the world's No.1 manufacturers of equipment for medical imaging, laboratory diagnostics and hospital information systems. In addition, the group is developing digital health services and services dedicated to health establishments. Net sales break down by activity as follows: - sale of imaging equipment and solutions (53%); - sale of diagnostic equipment (21%); - sale of solutions and services for cancer care (16.6%); - sale of advanced therapeutic solutions (9.4%): for image-guided minimally invasive treatments in the areas of cardiology, interventional radiology and surgery. Net sales are distributed geographically as follows: Germany (4.9%), Europe/CIS/Africa/Middle East (27.3%), the United States (34.6%), America (6.3%), China (13%) and Asia/Pacific and Japan (13.9%).
Sector
-
More about the company

Ratings for Siemens Healthineers AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Siemens Healthineers AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
53.5 EUR
Average target price
60.62 EUR
Spread / Average Target
+13.30%
Consensus